An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
News | ESC
News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...

Home April 10, 2024
Home
Study found no difference in troponin biomarkers up to one month after anthracycline treatment
News | Cardiovascular Clinical Studies
ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president.
News | Cardiovascular Business
Cathie Biga is New American College of Cardiology President

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
UC Davis is one of the first sites nationwide to treat tricuspid regurgitation using a minimally invasive catheter system
News | Structural Heart
Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...

Home April 09, 2024
Home
Subanalysis finds benefit for patients not on heart-beneficial antidiabetic medication
News | Cardiovascular Clinical Studies
New Drug Fails to Improve Diabetes-Related Heart Failure

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
Phase 2 trial shows early signs that the investigational drug could relieve symptoms and improve exercise capacity in HCM patients with no other evidence-based treatment options available
News | Cardiovascular Clinical Studies
Ninerafaxstat Well-Tolerated and Safe for Nonobstructive Hypertrophic Cardiomyopathy

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
Trial shows increased risk of bleeding with topical administration during open heart surgery
News | Cardiovascular Clinical Studies
Topical Tranexamic Acid Found Inferior to Intravenous Administration

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
Participants saw 35% reduction in LDL cholesterol, signaling the process could offer safe, effective non-prescription use of life-saving drug
News | Cardiovascular Clinical Studies
Study Shows Web App Effective in Determining Access to Statins Without a Prescription

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year
News | Cardiovascular Clinical Studies
Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
Infusions reduce lead levels but show no effect on clinical endpoints
News | Cardiovascular Clinical Studies
Chelation Therapy Does Not Improve Outcomes after Heart Attack

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Study suggests routine use is likely unnecessary for those with normal ejection fraction
News | Cardiovascular Clinical Studies
Beta Blockers May Not Benefit Many Heart Attack Survivors

April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...

Home April 08, 2024
Home
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
News | Cardiovascular Clinical Studies
Heart Pump Improves Survival After Severe Heart Attacks

April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...

Home April 08, 2024
Home
Ticagrelor alone outperforms 12-month DAPT for reducing bleeding with no increased risk
News | Cardiovascular Clinical Studies
Study Suggests Most Patients with Acute Coronary Syndromes Can Safely Stop Aspirin One Month After Percutaneous Coronary Intervention

April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin ...

Home April 08, 2024
Home
Earning points or small sums of money encourages people to ‘step up’ their physical activity
News | Cardiovascular Clinical Studies
Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease

April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...

Home April 07, 2024
Home
When added to standard blood pressure medication, new drug could minimize the need for pills and reduce cardiovascular risks
News | Cardiovascular Clinical Studies
One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...

Home April 07, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now